Cargando…

Valproic Acid-Induced CCN1 Promotes Osteogenic Differentiation by Increasing CCN1 Protein Stability through HDAC1 Inhibition in Tonsil-Derived Mesenchymal Stem Cells

Our previous study found that the level of CCN1 increases as osteogenic differentiation progresses in tonsil-derived mesenchymal stem cells (TMSCs). This study investigated how CCN1 is regulated through HDAC inhibition in TMSCs and their relationship with osteogenesis. Valproic acid (VPA) (1–5 mM),...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yeonsil, Oh, Se-Young, Kim, Ha Yeong, Choi, Ji-Young, Jo, Sangmee Ahn, Jo, Inho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834451/
https://www.ncbi.nlm.nih.gov/pubmed/35159343
http://dx.doi.org/10.3390/cells11030534
_version_ 1784649190084706304
author Yu, Yeonsil
Oh, Se-Young
Kim, Ha Yeong
Choi, Ji-Young
Jo, Sangmee Ahn
Jo, Inho
author_facet Yu, Yeonsil
Oh, Se-Young
Kim, Ha Yeong
Choi, Ji-Young
Jo, Sangmee Ahn
Jo, Inho
author_sort Yu, Yeonsil
collection PubMed
description Our previous study found that the level of CCN1 increases as osteogenic differentiation progresses in tonsil-derived mesenchymal stem cells (TMSCs). This study investigated how CCN1 is regulated through HDAC inhibition in TMSCs and their relationship with osteogenesis. Valproic acid (VPA) (1–5 mM), a well-known histone deacetylase (HDAC) inhibitor, strongly inhibited TMSC proliferation without altering MSC-specific surface markers, CD14, 34, 45, 73, 90 and 105. However, CD146 expression increased at 5 mM VPA. VPA increased osteogenic differentiation of TMSCs but decreased adipogenesis and chondrogenesis, as evidenced by the cell-specific staining of differentiation. The former was validated by the increased osteocalcin (OCN). The changes in CCN1 by VPA was biphasic; it increased until 48 h and decreased thereafter. Knockdown of CCN1 by using siRNA inhibited the osteogenic effect of VPA. VPA had no effect on CCN1 mRNA expression, but inhibition of protein synthesis by cycloheximide showed that VPA slowed down the CCN1 protein degradation. Moreover, overexpression of HDAC1 completely inhibited VPA-induced CCN1. Our results indicate that VPA inhibits the HDAC1, inducing CCN1 protein stability rather than gene expression, thereby promoting osteogenic differentiation of TMSCs. These findings present the noble implication of VPA as an inhibitor of HDAC1 to facilitate CCN1-induced osteogenic differentiation of MSCs.
format Online
Article
Text
id pubmed-8834451
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88344512022-02-12 Valproic Acid-Induced CCN1 Promotes Osteogenic Differentiation by Increasing CCN1 Protein Stability through HDAC1 Inhibition in Tonsil-Derived Mesenchymal Stem Cells Yu, Yeonsil Oh, Se-Young Kim, Ha Yeong Choi, Ji-Young Jo, Sangmee Ahn Jo, Inho Cells Article Our previous study found that the level of CCN1 increases as osteogenic differentiation progresses in tonsil-derived mesenchymal stem cells (TMSCs). This study investigated how CCN1 is regulated through HDAC inhibition in TMSCs and their relationship with osteogenesis. Valproic acid (VPA) (1–5 mM), a well-known histone deacetylase (HDAC) inhibitor, strongly inhibited TMSC proliferation without altering MSC-specific surface markers, CD14, 34, 45, 73, 90 and 105. However, CD146 expression increased at 5 mM VPA. VPA increased osteogenic differentiation of TMSCs but decreased adipogenesis and chondrogenesis, as evidenced by the cell-specific staining of differentiation. The former was validated by the increased osteocalcin (OCN). The changes in CCN1 by VPA was biphasic; it increased until 48 h and decreased thereafter. Knockdown of CCN1 by using siRNA inhibited the osteogenic effect of VPA. VPA had no effect on CCN1 mRNA expression, but inhibition of protein synthesis by cycloheximide showed that VPA slowed down the CCN1 protein degradation. Moreover, overexpression of HDAC1 completely inhibited VPA-induced CCN1. Our results indicate that VPA inhibits the HDAC1, inducing CCN1 protein stability rather than gene expression, thereby promoting osteogenic differentiation of TMSCs. These findings present the noble implication of VPA as an inhibitor of HDAC1 to facilitate CCN1-induced osteogenic differentiation of MSCs. MDPI 2022-02-03 /pmc/articles/PMC8834451/ /pubmed/35159343 http://dx.doi.org/10.3390/cells11030534 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yu, Yeonsil
Oh, Se-Young
Kim, Ha Yeong
Choi, Ji-Young
Jo, Sangmee Ahn
Jo, Inho
Valproic Acid-Induced CCN1 Promotes Osteogenic Differentiation by Increasing CCN1 Protein Stability through HDAC1 Inhibition in Tonsil-Derived Mesenchymal Stem Cells
title Valproic Acid-Induced CCN1 Promotes Osteogenic Differentiation by Increasing CCN1 Protein Stability through HDAC1 Inhibition in Tonsil-Derived Mesenchymal Stem Cells
title_full Valproic Acid-Induced CCN1 Promotes Osteogenic Differentiation by Increasing CCN1 Protein Stability through HDAC1 Inhibition in Tonsil-Derived Mesenchymal Stem Cells
title_fullStr Valproic Acid-Induced CCN1 Promotes Osteogenic Differentiation by Increasing CCN1 Protein Stability through HDAC1 Inhibition in Tonsil-Derived Mesenchymal Stem Cells
title_full_unstemmed Valproic Acid-Induced CCN1 Promotes Osteogenic Differentiation by Increasing CCN1 Protein Stability through HDAC1 Inhibition in Tonsil-Derived Mesenchymal Stem Cells
title_short Valproic Acid-Induced CCN1 Promotes Osteogenic Differentiation by Increasing CCN1 Protein Stability through HDAC1 Inhibition in Tonsil-Derived Mesenchymal Stem Cells
title_sort valproic acid-induced ccn1 promotes osteogenic differentiation by increasing ccn1 protein stability through hdac1 inhibition in tonsil-derived mesenchymal stem cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834451/
https://www.ncbi.nlm.nih.gov/pubmed/35159343
http://dx.doi.org/10.3390/cells11030534
work_keys_str_mv AT yuyeonsil valproicacidinducedccn1promotesosteogenicdifferentiationbyincreasingccn1proteinstabilitythroughhdac1inhibitionintonsilderivedmesenchymalstemcells
AT ohseyoung valproicacidinducedccn1promotesosteogenicdifferentiationbyincreasingccn1proteinstabilitythroughhdac1inhibitionintonsilderivedmesenchymalstemcells
AT kimhayeong valproicacidinducedccn1promotesosteogenicdifferentiationbyincreasingccn1proteinstabilitythroughhdac1inhibitionintonsilderivedmesenchymalstemcells
AT choijiyoung valproicacidinducedccn1promotesosteogenicdifferentiationbyincreasingccn1proteinstabilitythroughhdac1inhibitionintonsilderivedmesenchymalstemcells
AT josangmeeahn valproicacidinducedccn1promotesosteogenicdifferentiationbyincreasingccn1proteinstabilitythroughhdac1inhibitionintonsilderivedmesenchymalstemcells
AT joinho valproicacidinducedccn1promotesosteogenicdifferentiationbyincreasingccn1proteinstabilitythroughhdac1inhibitionintonsilderivedmesenchymalstemcells